New 3D method may improve tumor measurement accuracy
NCT ID NCT07319767
First seen Jan 10, 2026 · Last updated May 22, 2026 · Updated 19 times
Summary
This study looks at better ways to measure how tumors respond to treatment before surgery. Researchers compared a new 3D method (TDTP-RECIST) with the standard approach (RECIST 1.1) in 120 adults with breast, pancreatic, or biliary cancers. By reviewing past scans and tumor tissue, they aim to find which method best predicts treatment success. There were no treatments or visits for participants, so risks were minimal.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Zhongshan Hospital, Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.